Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention

Jochen Schacht1, Andra E Talaska, Leonard P Rybak

  • 1Department of Otolaryngology, Kresge Hearing Research Institute, University of Michigan, Ann Arbor, Michigan 48109-5616, USA. schacht@umich.edu

Insights

Aminoglycoside antibiotics and cisplatin chemotherapy cause inner ear damage, leading to hearing loss by triggering oxidative stress and cell death. Understanding these mechanisms may lead to protective pharmaceutical strategies.

Area of Science:

  • Ototoxicity research
  • Cellular and molecular biology
  • Pharmacology

Background:

  • Aminoglycoside antibiotics and cisplatin chemotherapy are clinically important drugs with ototoxic potential.
  • Both drug classes can induce sensorineural hearing loss, primarily affecting cochlear outer hair cells.
  • Aminoglycosides may also impact the vestibular system, whereas cisplatin has a lower likelihood of doing so.

Purpose of the Study:

  • To review the pathology of aminoglycoside and cisplatin ototoxicity.
  • To discuss the role of oxidative stress in inner ear cell damage.
  • To delineate cell death pathways and explore pharmaceutical protection strategies.

Main Methods:

  • Review of existing literature on aminoglycoside and cisplatin ototoxicity.
  • Analysis of mechanisms involving oxidative stress and cell death pathways in the inner ear.
  • Exploration of potential pharmaceutical interventions for cochlear protection.

Main Results:

  • Oxidative stress is identified as a key trigger for ototoxicity in the inner ear.
  • Specific cell death pathways are delineated following drug-induced damage.
  • Outer hair cell damage in the basal cochlea is a primary manifestation of hearing loss.

Conclusions:

  • Understanding the molecular mechanisms of ototoxicity is crucial for developing protective therapies.
  • Pharmaceutical strategies targeting oxidative stress and cell death pathways show promise for preventing cisplatin and aminoglycoside-induced hearing loss.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...